Dr. Reddy’s Laboratories launches Melgain lotion for treatment of Vitiligo

13 Jun 2014 Evaluate

Dr. Reddy’s Laboratories, an integrated global pharma company, has launched Melgain lotion, a patented drug that has been approved for the treatment of Vitiligo. The medication has been launched in partnership with Issar Pharmaceuticals to increase access to a novel treatment for Vitiligo patients in India.

Vitiligo is a skin disease that leads to white patches on the body due to the loss of normal skin pigment called melanin. It is a very common disease that affects all races and is estimated to affect about five crore people in India. Vitiligo leads to emotional distress as the disease affects the appearance of the patient.

Dr. Reddy’s is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, bio-similars, differentiated formulations and NCEs.

Dr. Reddys Lab Share Price

1268.60 -0.45 (-0.04%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×